Loyola University Medical Center
Locations
Transplant Summary
Overview
Formed in 1996, LUMC is a FACT-accredited transplant program affiliated with the SWOG clinical trials. We provide a multidisciplinary team approach to related, unrelated and auto transplants for adults with a variety of hematologic/solid tumor diseases. We offer CAR T cellular therapy using an FDA approved product and an in-house clinical trial.This center has been performing allogeneic transplants since 1986 and has been an NMDP transplant center since December 1996.
Attending physicians
Adult - Patrick Hagen, Jorgina Kosti, Imran Puthawala, Patrick J. Stiff, Stephanie TsaiTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
Our Bone Marrow Transplant and Cellular Therapy Program is a comprehensive adult program that is FACT accredited for both autologous and allogeneic transplants. We have discounted housing available within a few miles of campus through our nearby hotels. Our patients receive personalized care throughout the BMT process with a dedicated team of BMT physicians, Advanced Practice Providers (APPs) and a specifically assigned Transplant Nurse Coordinators. Our care team also includes BMT-specific RNs, Social Workers, Nutritionists, Clinical Pharmacist, Psychologists, and Physical Therapists.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 94 patients.The actual 1-year survival of these patients is 67%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 62.8% and 79.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
134
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC17Cord blood0Total18Unrelated donorMarrow12PBSC6Cord blood11Total29Total allogeneicMarrow13PBSC23Cord blood11Total47AutologousMarrowBoth marrow & PBSC 87PBSC—Cord blood—Total87Total combinedMarrowBoth marrow & PBSC 123PBSC—Cord blood11Total134All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44945-64765+2Total18Unrelated 0-18019-44645-641265+11Total29Autologous 0-18019-44745-644465+36Total87Total 0-18019-442245-646365+49Total134Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Bone Marrow Transplant Program
2160 S First Avenue, Building 112 Maywood, IL 60153 Phone:708-327-3210 Physician Referrals:888-584-7888 For more information about this program: https://www.loyolamedicine.org/cancer/bone-marrow-and-stem-cell-transplant (Opens in a new tab)Overview
Loyola's stem cell transplant survivorship program is aimed at maximizing quality of life and functioning in survivors after blood and marrow stem cell transplantation (BMT). The first evaluation occurs at about one year after transplant. Patients are comprehensively evaluated by organ system for any signs of graft versus host disease, as well as general organ dysfunction. If abnormalities are detected, they will be referred to specialists who have particular vested interest in the BMT population and its associated toxicities. Their primary care physicians are always integral members, and they receive a copy of this evaluation, as well as educational information and instructions on increasing vigilance in screening BMT patients for conditions for which they are at increased risk, such as cardiac issues, high blood pressure, metabolic syndrome, thyroid disorder, etc. Patients will continue to be seen by their primary BMT physician and affiliated nurse practitioners and team for ongoing monitoring and management of any post-transplant morbidities. This multidisciplinary program helps patients and their families transition back to living.
Staff
Program Director:Patrick Stiff, MDProgram Coordinator:Cathy Del Sarto, RNMedical Specialties in Program
Cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 1 year after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital